Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life

NCT: NCT07679074 · RECRUITING

NCT IDNCT07679074
StatusRECRUITING
Start Date2026-06-01
Completion2027-03-01
SponsorSamphire Group, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work productivity, employee wellbeing, and quality of life in individuals experiencing mood and cognitive symptoms associated with menstruation, perimenopause, or menopause.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑